MedPath

Transcranial Electrical Stimulation for Cervical Dystonia

Not Applicable
Completed
Conditions
Primary Cervical Dystonia
Interventions
Device: transcranial electrical stimulation
Registration Number
NCT03369613
Lead Sponsor
University of Colorado, Denver
Brief Summary

There are two phases.

Phase I: A single visit which includes a screening, clinical scales, and a MRI scan with simultaneous tES/sham tES in a randomized block design. Enrolls both Cervical Dystonia (CD) patients and healthy controls.

Phase II: 5 consecutive days of 30-90 min visits to campus for tES or sham tES. Transcranial magnetic stimulation (TMS) measures and clinical scales will also be included on Day 1 and Day 5 visits. Enrolls only CD patients.

Detailed Description

Phase I:

Enrolls both CD patients and healthy controls.

One approximately 3 hour visit which includes:

* a screening \& neurological exam,

* clinical scales \& questionnaires,

* a (approx.) 60 min MRI scan with simultaneous tES/sham tES in a randomized block design and EMG

Phase II:

Enrolls only CD patients.

Five consecutive days of study visits.

Day 1:

* TMS screening,

* repeated neurological assessment and clinical scales if \>1 month since MRI visit

* 30 min TMS session with concurrent EMG

* 20 min tES or sham tES session

Days 2-4:

- 20 min tES or sham tES session

Day 5:

* 20 min tES or sham tES session

* 30 min TMS session with concurrent EMG

* repeated neurological assessment and clinical scales

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Right-handed
  • On a stable dose of all medications used to treat dystonia for the month previous to enrollment
  • No botox injections in the 10 weeks previous to enrollment
Exclusion Criteria
  • Any contraindication to MRI scanning, tES, or TMS (e.g pregnancy, history of seizures, significant systemic medical conditions, untreated psychiatric or neurological conditions)
  • Evidence on neurological exam of any potentially confounding neurological disorder
  • Evidence of significant cognitive impairment
  • Patients with dystonia symptoms beginning prior to the age of 18 will be excluded
  • Patients with secondary dystonia resulting from medications or that are part of another neurological disorder (e.g. Parkinson's disease) will be excluded
  • Medication that might predispose the subject to seizures

Healthy Controls

Inclusion Criteria:

  • Right-handed

Exclusion Criteria:

  • Any contraindication to MRI scanning, tES, or TMS (e.g pregnancy, history of seizures, significant systemic medical conditions, untreated psychiatric or neurological conditions)
  • Evidence on neurological exam of any potentially confounding neurological disorder
  • Evidence of significant cognitive impairment
  • Medication that might predispose the subject to seizures

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MRI - HC tACStranscranial electrical stimulationHealthy controls in Phase 1- transcranial electrical stimulation set to alternating current
MRI - CD tCDStranscranial electrical stimulationCervical dystonia in Phase 1 transcranial electrical stimulation set to direct current
MRI - HC tDCStranscranial electrical stimulationHealthy controls in Phase 1 transcranial electrical stimulation set to direct current
Phase II - Stimtranscranial electrical stimulationCervical dystonia in Phase 2 transcranial electrical stimulation setting is active
MRI - CD tACStranscranial electrical stimulationCervical dystonia in Phase 1 transcranial electrical stimulation set to alternating current
Phase II - Shamtranscranial electrical stimulationCervical dystonia in Phase 2 transcranial electrical stimulation setting is sham
Primary Outcome Measures
NameTimeMethod
Phase II: Improvement in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scoreDay 1, Day 5

A change in TWSTRS scores following five daily sessions of inhibitory tACS.

Phase I: A change in brain functional connectivity in primary cervical dystoniaDay 1

A change in mean functional connectivity between the pallidum and putamen during a resting state in CD patients during inhibitory tACS targeting the sensorimotor network.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Colorado Denver

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath